Exelixis (EXEL) Debt Ratio (2010 - 2017)
Exelixis (EXEL) posted quarterly Debt Ratio of 0.19 for Q1 2017, down 11.52% year-over-year from 0.22 in Q1 2016, and up 5.42% quarter-over-quarter from 0.18 in Q4 2016.
Exelixis (EXEL) Debt Ratio (2010 - 2017) Analysis & Trends
Exelixis' Debt Ratio history runs 8 years deep, the most recent figure standing at 0.19 for Q1 2017.
- In Q1 2017, Debt Ratio fell 11.52% year-over-year to 0.19; the TTM figure through Mar 2017 stood at 0.19 (down 11.52% YoY), while the FY2016 annual figure was 0.18, down 23.91% from the prior year.
- Debt Ratio for Q1 2017 stood at 0.19, up from 0.18 in the prior quarter.
- The five-year high for Debt Ratio was 0.55 in Q4 2014, with the low at 0.05 in Q3 2016.
- The 5-year median for Debt Ratio is 0.19 (2017), against an average of 0.23.
- The sharpest annual moves came in 2014 and 2016: Debt Ratio surged 205.85% in 2014, then plunged 82.08% in 2016.
- Exelixis' Debt Ratio stood at 0.18 in 2013, then soared by 205.85% to 0.55 in 2014, then plunged by 56.15% to 0.24 in 2015, then dropped by 23.91% to 0.18 in 2016, then grew by 5.42% to 0.19 in 2017.
- Business Quant data shows EXEL's Debt Ratio at 0.19 in Q1 2017, 0.18 in Q4 2016, and 0.05 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Exelixis | 12.75 Bn | 11.91 Bn | 608.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 0.19 |
| Dec 30, 2016 | 0.18 |
| Sep 30, 2016 | 0.05 |
| Jun 30, 2016 | 0.06 |
| Mar 31, 2016 | 0.22 |
| Dec 31, 2015 | 0.24 |
| Sep 30, 2015 | 0.22 |
| Jun 30, 2015 | 0.32 |
| Mar 31, 2015 | 0.30 |
| Dec 31, 2014 | 0.55 |
| Sep 30, 2014 | 0.46 |
| Jun 30, 2014 | 0.40 |
| Mar 31, 2014 | 0.16 |
| Dec 31, 2013 | 0.18 |
| Sep 30, 2013 | 0.16 |
| Jun 30, 2013 | 0.15 |
| Mar 31, 2013 | 0.14 |
| Dec 31, 2012 | 0.13 |
| Sep 30, 2012 | 0.12 |
| Jun 30, 2012 | 0.25 |